Glaucoma Today

Glaucoma Today Glaucoma Today delivers information on recent research, surgical techniques, clinical strategies, therapeutics, and technology. A BMC Vision publication.

GT offers readers balanced coverage of the topics that matter most! Glaucoma Today is mailed bimonthly (six times a year) to 11,121 glaucoma specialists, general ophthalmologists, and clinical optometrists who treat patients with glaucoma. The publication profiles leaders in the field of glaucoma, and contributing authors present challenging cases as a source of education for readers. Glaucoma Tod

ay delivers balanced coverage of the topics that matter most. Twitter: https://twitter.com/GlaucomaToday
Instagram: https://www.instagram.com/glaucomatoday/

Learn where the MINIject supraciliary MIGS device fits into Dr. I. Paul Singh’s glaucoma treatment paradigm. He discusse...
12/10/2024

Learn where the MINIject supraciliary MIGS device fits into Dr. I. Paul Singh’s glaucoma treatment paradigm. He discusses the device’s safety and efficacy and shares his clinical experience. Watch here: https://bit.ly/4imp1lk

MINIject is an investigational device in the US and not for sale.

ViaLase announced a research partnership with the John A. Moran Eye Center at the University of Utah (Moran Eye Center),...
12/10/2024

ViaLase announced a research partnership with the John A. Moran Eye Center at the University of Utah (Moran Eye Center), home to the Alan S. Crandall Center for Glaucoma Innovation (Crandall Center). The collaboration will explore aqueous outflow dynamics of ViaLase’s ViaLase laser procedure, utilizing Moran’s iPerfusion technology: https://bit.ly/4fbHGNO

12/04/2024

Austin Bohner, MD, and Craig Chaya, MD, present their preferred surgical bleb revision technique they call "excise and mobilize." The technique involves removing necrotic tissue and advancing healthy conjunctiva.

They say this approach preserves the flap filtration architecture and it is imperative to use a sharp instrument to facilitate the dissection plane. If inadequate conjunctiva remains for closure, shunt removal and patch grafting may be necessary. Continue watching here: https://bit.ly/3D9wF2d

12/02/2024

This episode features two articles recently published in Glaucoma Today. First, Shannan Moore, BS, recaps her article—“Is There a Link Between Chronic Stress, Autonomic Dysregulation, and Glaucomatous Progression?”—which was written with Garrick Chak, MD, and makes the case that it may be worthwhile to incorporate questions about chronic emotional stressors into patient encounters.

Then, Mona Kaleem, MD, recaps her article—“Advances in Eye Drop Aids”—which was written with Delcora Huggins, BS, and reviews four available solutions to help overcome the challenges associated with eye drop administration. Listen on here: https://bit.ly/3OAddyb

11/26/2024

Dr. Manjool Shah discusses a complicated case in which a patient implanted with a Xen Gel Stent experienced an IOP spike after 6 months. Dr. Shah describes his approach to the revision of the Xen and implantation of an Ahmed Glaucoma Valve. Watch: https://bit.ly/3CCinqB

11/21/2024

In this episode, Dr. Nishani Amerasinghe reviews 5-year data behind Hydrus Microstent implantation, sharing insights into insertion techniques to help shorten the learning curve and improve visualization during the procedure. Watch here: https://bit.ly/495JW7Z

11/15/2024

To set clear expectations for patients, surgeons rely on clinical trial data to support treatment decisions. In this article, Dr. Inder Paul Singh reviews the data behind the iDose TR and explains how it can help reduce a patient’s drop burden. Read here: https://bit.ly/4hTUCL9

Are you attending Caribbean Eye Meeting this year? Save $100 by registering today!
11/14/2024

Are you attending Caribbean Eye Meeting this year? Save $100 by registering today!

ACT FAST! For a limited time, you can take $100 off registration for the 2025 Caribbean Eye Meeting in San José del Cabo, Mexico! 💰Join well-known leaders in ophthalmology to discuss important topics in eye care and earn CME/COE credits! Learn more: https://www.caribbeaneyemeeting.com/

11/13/2024

The 2025 Caribbean Eye Meeting is your chance to collaborate with leaders in ophthalmology in discussing important topics and earn CME/COE credits while connecting, recharging, and elevating your practice in unparalleled tropical splendor. 🏝️ Register here: https://bit.ly/3YE2cjW

Could Chronic Stress Impact Glaucoma Progression?  Glaucoma Today's latest article explores the potential link between c...
11/13/2024

Could Chronic Stress Impact Glaucoma Progression?

Glaucoma Today's latest article explores the potential link between chronic stress, autonomic dysregulation, and glaucoma progression. A must-read for anyone interested in the complex factors affecting eye health.

Read the full article from Shannan G. Moore, BS, and Garrick Chak, MD: https://bit.ly/3AuYPEd

It may be worthwhile to incorporate questions about chronic emotional stressors into patient encounters.

11/13/2024

MediPrint Ophthalmics announced positive results from its phase 2b clinical trial of its 3D-printed, drug-eluting contact lens LL-BMT1:

MediPrint Ophthalmics announced positive results from its phase 2b clinical trial of its 3D-printed, drug-eluting contact lens LL-BMT1.&nb

11/07/2024

Jason Xiao, BS, recaps “Improving the Affordability of Glaucoma Medications,” which was featured in the May/June issue of Glaucoma Today. The article explores strategies to address the financial barriers to glaucoma medication adherence and reviews an initiative by the University of Chicago Medicine to help reduce patients’ out-of-pocket pharmacy costs: https://bit.ly/3UCeGaz

Dr. John Berdahl examines outcomes from the iDose clinical trial in eyes with prior selective or micropulse laser trabec...
11/05/2024

Dr. John Berdahl examines outcomes from the iDose clinical trial in eyes with prior selective or micropulse laser trabeculoplasty. Learn how the data determine if treatment with iDose is as effective in patients who had prior SLT or MLT compared to the larger population. See more: https://bit.ly/3NSfdSh

ISI Link: https://bit.ly/3K7P9R6

Glaucoma drainage implants can be very effective for lowering IOP in patients with glaucoma, but postoperative hypotony ...
11/04/2024

Glaucoma drainage implants can be very effective for lowering IOP in patients with glaucoma, but postoperative hypotony is a potential and dreaded complication associated with their use.

The ability to control pressure fluctuations following surgery can help to minimize this concern. A drainage device that is titratable puts IOP control in the hands of the surgeon from postoperative day 1, thereby serving to prevent hypotony and better manage IOP.

Continue reading this editorial from Karl Mercieca, MD, PGCME, FRCOphth, FEBOS-GL here:

A new avenue for greater IOP control.

10/31/2024

I. Paul Singh, MD, shares a case of combination cataract surgery and iStent infinite (Glaukos) implantation. He explains how you can see the balanced salt solution leaving the anterior chamber into the episcleral veins as the eye is pressurized.

Instead of burping the wound, he pushes on the cornea and lets the fluid leave through the venous system.

He says this prevents hyphema and also confirms the stents are in good position, proving that there is significant outflow. Continue watching here: https://bit.ly/3NLVIKP

10/31/2024
This prospective, multicenter, masked, randomized controlled trial compared the IOP reduction and the time to glaucoma t...
10/29/2024

This prospective, multicenter, masked, randomized controlled trial compared the IOP reduction and the time to glaucoma treatment escalation with four different selective laser trabeculoplasty (SLT) treatment protocols.

Investigators assessed 400 patients (513 eyes) who had primary open-angle glaucoma, pseudoexfoliative glaucoma, or ocular hypertension. Individuals who had previously undergone laser treatment and/or were currently receiving glaucoma medical therapy were allowed.

Those who had a history of glaucoma surgery, a highly pigmented trabecular meshwork, intraocular inflammatory disease within the previous year, or a change in glaucoma medication within the previous 3 months were excluded.

Continue reading this editorial on "Optimizing Surgical Technique" from Yvonne Okaka, MD, and Charles A. Cole, MD here:

Studies sought to determine the best protocols for two procedures.

A 49-year-old White woman presents to the emergency department. Her left eye exhibits acute angle closure and has an IOP...
10/28/2024

A 49-year-old White woman presents to the emergency department. Her left eye exhibits acute angle closure and has an IOP of 67 mm Hg. Her right eye exhibits primary angle closure and has an IOP of 27 mm Hg. The patient was diagnosed with narrow angles in 2014 but did not proceed with a laser peripheral iridotomy (LPI) at the time.

Continue reading this editorial from Devesh K. Varma, MD, FRCSC; Sunee Chansangpetch, MD, BPH; and Shan C. Lin, MD here: https://bit.ly/3Uq1ju6

Address

Wayne, PA

Alerts

Be the first to know and let us send you an email when Glaucoma Today posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Glaucoma Today:

Videos

Share

Category


Other Publishers in Wayne

Show All